R&D
Why the best CROs challenge the trial plan and keep challeng...
Too often, oncology trials fail for reasons that could have been anticipated and addressed.
News
AbbVie invests £120m in UK expansion
AbbVie has pledged another £120 million to the UK, reinforcing the country's recovery as a pharma industry investment hotspot.
News
German sites added to Europe's cardiometabolic R&D network
The BioInnovation Institute (BII) has expanded a European network to develop drugs for cardiometabolic diseases and launch new biotechs into Germany.
News
Case study backs YolTech's AATD gene therapy
A gene therapy for alpha-1 antitrypsin deficiency developed by China's YolTech has successfully treated a patient with a severe form of the disease.
News
Merck charts course out of CDMO business with Lonza sale
Merck KGaA has moved to streamline its focus with the sale of its contract development and manufacturing organisation (CDMO) business to Lonza.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
